• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD. BD RAPID DETECTION OF SARS-COV-2 VERITOR¿; CORONAVIRUS ANTIGEN DETECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD. BD RAPID DETECTION OF SARS-COV-2 VERITOR¿; CORONAVIRUS ANTIGEN DETECTION SYSTEM Back to Search Results
Catalog Number 256089
Device Problem Leak/Splash (1354)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/03/2022
Event Type  Injury  
Manufacturer Narrative
Eua# (b)(4).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the assistant in nursing used the control swab from the bd rapid detection of sars-cov-2 veritor¿ to test herself, therefore, exposing herself to reagent.Eua# (b)(4).The following information was provided by the initial reporter: the receptionist from care home called to say that an ain (assistant in nursing) didn't follow the instructions of use & used the green swab ( sars cov-2 (+) control swab in green satchel) to perform a sars cov-2 test on herself at 8am this morning & tested positive.The ain repeated the test using a clean swab & tested positive again.There concern was whether the ain became infected by the positive control swab.
 
Manufacturer Narrative
H.6 investigation summary: this summarizes the investigation results regarding a complaint that alleges exposure to reagent when using kit rapid detection of sars-cov-2 veritor ce (material # 256089), batch number 1270839.Bd quality performs a systematic approach to investigate exposure to reagent complaints.This approach involves review of manufacturing batch history records, visual inspection of retention samples, and visual inspection of customer returned samples, if applicable.A batch history record (bhr) review and retain sample analysis were not performed for this reported issue due to the nature of the complaint and it was not alleging any product quality.Based on the primary investigation understood that customer did not follow the instructions properly.Swab controls are supplied with each kit.These swab controls should be used to ensure that the test reagents work properly and that the test procedure is performed correctly.For kit swab controls, insert the control swab into the extraction reagent tube and vigorously plunge the swab up and down for 15 seconds and need to be tested to verify.If the kit controls do not perform as expected, do not report patient results.The complaint was unable to be confirmed.The root cause could not be identified.Currently no adverse trend for exposure to reagent was identified.Bd quality will continue to closely monitor for trends.If you have any add ions or concerns, please do not hesitate to contact bd technical services.
 
Event Description
It was reported that the assistant in nursing used the control swab from the bd rapid detection of sars-cov-2 veritor¿ to test herself, therefore, exposing herself to reagent.Eua# (b)(4).The following information was provided by the initial reporter: the receptionist from care home called to say that an ain (assistant in nursing) didn't follow the instructions of use & used the green swab ( sars cov-2 (+) control swab in green satchel) to perform a sars cov-2 test on herself at 8am this morning & tested positive.The ain repeated the test using a clean swab & tested positive again.There concern was whether the ain became infected by the positive control swab.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD RAPID DETECTION OF SARS-COV-2 VERITOR¿
Type of Device
CORONAVIRUS ANTIGEN DETECTION SYSTEM
Manufacturer (Section D)
BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD.
9 rui pu road export zone b
suzhou
CH 
Manufacturer (Section G)
BD RAPIS DIAGNOSTICS (SUZHOU) CO. LTD.
9 rui pu road export zone b
suzhou
CH  
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key14578754
MDR Text Key293279236
Report Number3006948883-2022-00125
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/02/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date09/09/2022
Device Catalogue Number256089
Device Lot Number1270839
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/20/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/27/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-